help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 11, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-1888
A more recent version of this article appeared on April 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/4/2187    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POPOVIC, V.
Right arrow Articles by CASANUEVA, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POPOVIC, V.
Right arrow Articles by CASANUEVA, F. F.

Submitted on September 24, 2004
Accepted on January 4, 2005

Low plasma ghrelin level in gastrectomized patients is accompanied with enhanced sensitivity to the ghrelin-induced growth hormone release

VERA POPOVIC*, DRAGANA MILJIC, SANDRA PEKIC, PREDRAG PESKO, MARINA DJUROVIC, MIRJANA DOKNIC, SVETOZAR DAMJANOVIC, DRAGAN MICIC, GORAN CVIJOVIC, JOVANA GLODIC, CARLOS DIEGUEZ, and FELIPE F. CASANUEVA

Institute of Endocrinology, Diabetes & Metabolism (VP, DM, SP, SD, MD, MD, DM, GC), Institute of Abdominal Surgery (PP), University Clinical Center, Belgrade, Laboratory Consilium (JG), Belgrade, Serbia & Montenegro, Dept. of Physiology (CD) and Complejo Hospitalario, Endocrine Section (FFC), Faculty of Medicine, Santiago de Compostela University, Santiago de Compostela, Spain

* To whom correspondence should be addressed. E-mail: popver{at}Eunet.Yu.

Ghrelin is brain-gut peptide with potent growth hormone (GH) releasing activities. It has been suggested that the majority of circulating ghrelin originates from the stomach, with a smaller portion from the small intestine. Gastrectomy significantly reduces circulating ghrelin concentrations. The implication of decreased circulating ghrelin on the somatotropic axis post-gastrectomy has not been studied. Therefore we aimed to investigate the somatotropic axis in ten gastrectomized (GASTRX) patients who underwent total gastrectomy for various reasons at least two years ago. At baseline circulating total-ghrelin, GH, IGF-I, IGFBP-3 levels were measured. The GH stimulation test was: insulin-induced hypoglycemia (ITT), ghrelin in two i.v. bolus doses (0.1 and 1 µg/kg) and GHRH test. GH sensitivity was assessed by an IGF-1 generation test. All the tests were performed two weeks apart.

At baseline serum ghrelin levels were reduced by 55% in GASTRX compared with the control group (P < 0.05). IGF-I (P < 0.05) and IGFBP-3 (P < 0.01) levels were also significantly lower than in controls. GH response to ITT in both GASTRX and control subjects was of similar magnitude, while circulating plasma ghrelin levels in GASTRX patients were not modified during hypoglycemia. Both doses (0.1 and 1.0 µg/kg) of ghrelin stimulated GH release significantly more in GASTRX than in control subjects, respectively (peak mean GH ± SE: 18.2 ± 5.6 vs. 5.4 ± 1.3 µg/L, P < 0.03 and 58.7 ± 7.5 vs. 35.3 ± 1.9 µg/L, P < 0.01). There was no difference in GHRH-induced GH response between GASTRX patients and control subjects (P > 0.05). Concomitantly, increased increments in IGF-I and IGFBP-3 to a single bolus of GH were found (P < 0.03). In conclusion, our data suggest that low circulating ghrelin levels, found in GASTRX patients, are accompanied by enhanced ghrelin sensitivity in respect of GH response. This is associated with increased GH responsiveness. Gastrectomy is a state of acquired chronic hypoghrelinemia that may require replacement with ghrelin and it is tempting to speculate that this may affect the GH-IGF-IGFBP axis.


Key words: ghrelin • GH • IGF-I • leptin




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
N. Wierup, M. Bjorkqvist, B. Westrom, S. Pierzynowski, F. Sundler, and K. Sjolund
Ghrelin and Motilin Are Cosecreted from a Prominent Endocrine Cell Population in the Small Intestine
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3573 - 3581.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. S. Damjanovic, N. M. Lalic, P. M. Pesko, M. S. Petakov, A. Jotic, D. Miljic, K. S. Lalic, L. Lukic, M. Djurovic, and V. B. Djukic
Acute Effects of Ghrelin on Insulin Secretion and Glucose Disposal Rate in Gastrectomized Patients
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2574 - 2581.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Miljic, S. Pekic, M. Djurovic, M. Doknic, N. Milic, F. F. Casanueva, M. Ghatei, and V. Popovic
Ghrelin Has Partial or No Effect on Appetite, Growth Hormone, Prolactin, and Cortisol Release in Patients with Anorexia Nervosa
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1491 - 1495.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society